Back

Effectiveness of high- versus low-dose four-factor prothrombin complex concentrate on hemostasis and thromboembolism in patients with oral factor Xa inhibitor-associated intracranial hemorrhage

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Oral anticoagulation: minimising bleeding Anticoagulants ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor William Baker

University of Connecticut, Storrs (United States of America)

5 More presentations in this session

Presentation thumbnail
Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation
Doctor G. Denas (Motta Di Livenza, IT)
Abstract Slides Video
Presentation thumbnail
DNA methylation of ADAMTS7 gene promoter in direct oral anticoagulant-induced bleeding in patients with atrial fibrillation
Miss N. Atzemian (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Factor XI inhibitors in early clinical trials: a meta-analysis
Doctor M. Galli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants in ambulatory care: a prospective interventional study in community pharmacies
Mr A. Capiau (Ghent, BE)
Abstract Slides Video
Presentation thumbnail
Comparison of Antithrombotic Regimens after Left Atrial Appendage Occlusion: A Systematic Review and Network Meta-analysis
Doctor L. KUBRUSLY (Curitiba, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Oral anticoagulation: minimising bleeding

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
A meta-analysis of high-dose versus low-dose 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitor-associated intracerebral hemorrhage
thumbnail
Congress Presentation
Factor Xa inhibitor associated major bleeding characteristics, burden, and health resource utilization in Alberta, Canada - an observational population based study
thumbnail
Congress Presentation
Characterisation of the pharmacokinetic and pharmacodynamic relationship of milvexian in total knee replacement patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources